Trademark247.com - Trademark Search Results

Showing 1-20 of 276 results

Mark Name	Mark Description
ZURNAI Owned by: PURDUE PHARMA L... Filed on: 06-12-2024 Status: New Application-Record in...	Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; In	View Details Monitor Mark Create New Watchlist
NALMEFENE HCL Owned by: PURDUE PHARMA L... Filed on: 03-10-2022 Status: Third Extension-Granted	Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Sy	View Details Monitor Mark Create New Watchlist
Owned by: PURDUE PHARMA L... Filed on: 03-10-2022 Status: Fourth Extension-Granted	Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Sy	View Details Monitor Mark Create New Watchlist
K Owned by: PURDUE PHARMA L... Filed on: 11-18-2021 Status: Second Extension-Granted	A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose,	View Details Monitor Mark Create New Watchlist
K KNOA PHARMA Owned by: PURDUE PHARMA L... Filed on: 11-18-2021 Status: Notice of Allowance-Issue...	A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose,	View Details Monitor Mark Create New Watchlist
KNOA PHARMACEUTICALS Owned by: PURDUE PHARMA L... Filed on: 09-02-2021 Status: Second Extension-Granted	A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose,	View Details Monitor Mark Create New Watchlist
KNOA PHARMA Owned by: PURDUE PHARMA L... Filed on: 09-02-2021 Status: Second Extension-Granted	A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose,	View Details Monitor Mark Create New Watchlist
NAMFERO Owned by: PURDUE PHARMA L... Filed on: 02-08-2021 Status: Fifth Extension-Granted	Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Sy	View Details Monitor Mark Create New Watchlist
ZALLQU Owned by: PURDUE PHARMA L... Filed on: 02-08-2021 Status: Fifth Extension-Granted	Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Sy	View Details Monitor Mark Create New Watchlist
NYMCERO Owned by: PURDUE PHARMA L... Filed on: 02-08-2021 Status: Fifth Extension-Granted	Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Sy	View Details Monitor Mark Create New Watchlist
NYLREVA Owned by: PURDUE PHARMA L... Filed on: 02-08-2021 Status: Fifth Extension-Granted	Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Sy	View Details Monitor Mark Create New Watchlist
IMBRIUM THERAPEUTICS Owned by: PURDUE PHARMA L... Filed on: 06-14-2019 Status: Registered	Pharmaceutical preparations for the treatment of central nervous system disorders	View Details Monitor Mark Create New Watchlist
IMBRIUM THERAPEUTICS Owned by: PURDUE PHARMA L... Filed on: 06-14-2019 Status: Registered	Pharmaceutical preparations for the treatment of central nervous system disorders	View Details Monitor Mark Create New Watchlist
IMBRIUM THERAPEUTICS Owned by: PURDUE PHARMA L... Filed on: 08-27-2018 Status: Registered	Pharmaceutical preparations for the treatment of central nervous system disorders	View Details Monitor Mark Create New Watchlist
ADHANSIA XR Owned by: PURDUE PHARMA L... Filed on: 01-16-2018 Status: Registered	Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treat	View Details Monitor Mark Create New Watchlist
IMBRIUM THERAPEUTICS Owned by: PURDUE PHARMA L... Filed on: 06-14-2019 Status: Abandoned-No Statement of...	Pharmaceutical preparations for the treatment of cancer; analgesic preparations	View Details Monitor Mark Create New Watchlist
IMBRIUM THERAPEUTICS Owned by: PURDUE PHARMA L... Filed on: 06-14-2019 Status: Abandoned-No Statement of...	Pharmaceutical preparations for the treatment of cancer; analgesic preparations	View Details Monitor Mark Create New Watchlist
MANIFEST PHARMA Owned by: PURDUE PHARMA L... Filed on: 08-27-2018 Status: Abandoned-No Statement of...	Pharmaceutical preparations for the treatment of cancer and central nervous system disorders; analgesic preparations	View Details Monitor Mark Create New Watchlist
MANIFEST THERAPEUTICS Owned by: PURDUE PHARMA L... Filed on: 08-27-2018 Status: Abandoned-No Statement of...	Pharmaceutical preparations for the treatment of cancer and central nervous system disorders; analgesic preparations	View Details Monitor Mark Create New Watchlist
MANIFEST LIFESCIENCES Owned by: PURDUE PHARMA L... Filed on: 08-27-2018 Status: Abandoned-No Statement of...	Pharmaceutical preparations for the treatment of cancer and central nervous system disorders; analgesic preparations	View Details Monitor Mark Create New Watchlist

Preparing summary view, please wait...

Owner Summary

This report includes a summary of your search results. The 'Marks Matched' column indicates the number of results that match a particular trademark owner, It does not include all of their other marks.

Primary Classification Summary

Status Summary

File Year Summary

Registration Statistics

Quick Links

Stay In Touch

Updated Daily